Danaher (DHR) Stock Forecast: StockMap's 2-Week Call
DHR stock forecast: StockMap's model makes no two-week call on Danaher after the Nov 13 close: its evidence is split, 6 reasons for and 9 against. Too few two-week windows graded to judge yet.
Danaher last closed at $233.02, +0.37% on the session.
Against the IVW growth benchmark the position is +1.28% over the forecast window.
Danaher's market cap is $163.94B as of November 13, 2026, #74 in the S&P 500.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 18 (too close to call).
Where DHR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 6 bullish and 9 bearish.
Agreement across those insights is 40%.
10 daily calls for DHR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Danaher in the 18th percentile on valuation and the 55th percentile on return on equity, where 100 is best.
Danaher is classified under Health Care / Life Sciences Tools & Services.
StockMap tracks Danaher as the 2nd largest of the 42 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 25 Neutral, 13 Moderate Outperform, 3 Moderate Underperform and 1 Strong Underperform.
On that composite Danaher ranks 14th of 42 in the group, against a group median of +0.13.